Literature DB >> 12117734

Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study.

Lewis Kuller1, Alice Arnold, Russell Tracy, James Otvos, Greg Burke, Bruce Psaty, David Siscovick, David S Freedman, Richard Kronmal.   

Abstract

OBJECTIVES: Relationships between incident cardiovascular disease and lipoprotein subclass measurements by nuclear magnetic resonance spectroscopy were evaluated in the Cardiovascular Health Study (CHS) in a nested case-cohort analysis. METHODS AND
RESULTS: The case group consisted of 434 participants with incident myocardial infarction (MI) and angina diagnosed after entry to the study (1990 to 1995) and the comparison group, 249 "healthy" participants with no prevalent clinical or subclinical disease. By univariate analysis, the median levels for healthy participants versus participants with incident MI and angina were 0 versus 7 mg% for small low density lipoprotein (LDL), 1501 versus 1680 nmol/L for the number of LDL particles, and 21.6 versus 21.3 for LDL size, and these values were significantly different between "healthy" participants and those with incident MI and angina for women but not men. The levels of less dense LDL, which is most of the total LDL cholesterol among women, was not related to incident MI and angina. For women, large high density lipoprotein cholesterol (HDLc), but not small HDLc, levels were significantly higher for healthy participants compared with levels for participants with MI and angina. For men and women, levels of total and very low density lipoprotein triglycerides were higher for the case group than for the healthy group. In multivariate models for women that included triglycerides and HDLc, the number of LDL particles (but not LDL size) remained significantly related to MI and angina.
CONCLUSIONS: Small LDL, the size of LDL particles, and the greater number of LDL particles are related to incident coronary heart disease among older women.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117734     DOI: 10.1161/01.atv.0000022015.97341.3a

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  90 in total

Review 1.  Low-density lipoprotein particle number and risk for cardiovascular disease.

Authors:  William C Cromwell; James D Otvos
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

2.  The clinical trial of Women On the Move through Activity and Nutrition (WOMAN) study.

Authors:  Lewis H Kuller; Andrea M Kriska; Laura S Kinzel; Laurey R Simkin-Silverman; Kim Sutton-Tyrrell; B Delia Johnson; Molly B Conroy
Journal:  Contemp Clin Trials       Date:  2006-10-14       Impact factor: 2.226

3.  HIV, HAART, and lipoprotein particle concentrations in the Women's Interagency HIV Study.

Authors:  Phyllis C Tien; Michael F Schneider; Christopher Cox; Mardge Cohen; Roksana Karim; Jason Lazar; Mary Young; Marshall J Glesby
Journal:  AIDS       Date:  2010-11-27       Impact factor: 4.177

Review 4.  Dietary fats and oils: technologies for improving cardiovascular health.

Authors:  Brent D Flickinger; Peter J Huth
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

5.  Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study.

Authors:  Carlos Lorenzo; Sara Hartnett; Anthony J Hanley; Marian J Rewers; Lynne E Wagenknecht; Andrew J Karter; Steven M Haffner
Journal:  J Clin Endocrinol Metab       Date:  2013-02-28       Impact factor: 5.958

6.  Lipoprotein Changes in HIV-Infected Antiretroviral-Naïve Individuals after Starting Antiretroviral Therapy: ACTG Study A5152s Stein: Lipoprotein Changes on Antiretroviral Therapy.

Authors:  James H Stein; Lauren Komarow; Bruno R Cotter; Judith S Currier; Michael P Dubé; Carl J Fichtenbaum; Mariana Gerschenson; Carol K C Mitchell; Robert L Murphy; Kathleen Squires; Robert A Parker; Francesca J Torriani
Journal:  J Clin Lipidol       Date:  2008-12       Impact factor: 4.766

7.  High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection.

Authors:  Jason Baker; Woubeshet Ayenew; Harrison Quick; Katherine Huppler Hullsiek; Russell Tracy; Keith Henry; Daniel Duprez; James D Neaton
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

8.  Lipoprotein particle subclasses, cardiovascular disease and HIV infection.

Authors:  Daniel A Duprez; Lewis H Kuller; Russell Tracy; James Otvos; David A Cooper; Jennifer Hoy; Jacqueline Neuhaus; Nicholas I Paton; Nina Friis-Moller; Fiona Lampe; Angelike P Liappis; James D Neaton
Journal:  Atherosclerosis       Date:  2009-05-13       Impact factor: 5.162

9.  Coronary artery endothelial dysfunction is positively correlated with low density lipoprotein and inversely correlated with high density lipoprotein subclass particles measured by nuclear magnetic resonance spectroscopy.

Authors:  Monique A Ford; Joseph P McConnell; Shahar Lavi; Charanjit S Rihal; Abhiram Prasad; Gurpreet S Sandhu; Stacy J Hartman; Lilach O Lerman; Amir Lerman
Journal:  Atherosclerosis       Date:  2009-05-06       Impact factor: 5.162

Review 10.  Physical activity and its effects on lipids.

Authors:  Philippe O Szapary; LeAnne T Bloedon; Gary D Foster
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.